
Ian S. Hagemann, MD, PhD
Professor, Pathology & Immunology
Contact
- Email: hagemani@wustl.edu
- Phone: 314 747-8924
Titles
Director, Gynecologic and Breast Pathology Fellowship
Assistant Dean for Admissions, Washington University School of Medicine
Education
A.B., Princeton University (2000), Chemistry, certificate in French Language and Culture
MD, Washington University, St. Louis, MO (2008)
PhD, Washington University, St. Louis, MO (2008)
Resident and Chief Resident: Anatomic Pathology, Hospital of the University of Pennsylvania (2008-2011)
Surgical Pathology Fellowship: Washington University, St. Louis (2012)
Molecular Genetic Pathology Fellowship: Washington University, St. Louis (2013)
Boards
2019 – Physician, Michigan Board of Medicine
2019 – Board Certified in Clinical Informatics, American Board of Pathology
2014 – Physician, Illinois State Medical Licensing Board
2011 – Physician and Surgeon, Missouri Board of Healing Arts
2013 – Board Certified in Molecular Genetic Pathology, American Board of Pathology and American Board of Medical Genetics
2011 – Board Certified in Anatomic Pathology, American Board of Pathology
Recognition
2025 – Co-chair, Education Committee, International Society of Gynecological Pathologists
2025 – Distinguished Alumni Scholarship Program (DASP) honoree, WashU Medicine
2024 – Prix Belgrand-Chevassu, Académie Nationale de Médecine (France)
2023 – Exceptional Educator Award, Academy of Educators, WUSM
2023 – Alpha Omega Alpha, WUSM
2020-2022 – Carol B. and Jerome T. Loeb Teaching Fellow
2020–Pres – Member, Gynecologic Expert Panel, AJCC Cancer Staging System, 9th ed.
2019 – Academy of Educators, WUSM
2019 – Distinguished Service Teaching Award from the Class of 2021, WUSM
2018 – Distinguished Service Teaching Award from the Class of 2020, WUSM
2015 – Distinguished Service Teaching Award from the Class of 2017, WUSM
2014–2018 – Member, Gynecologic Expert Panel, AJCC Cancer Staging System, 8th ed.
2013 – Distinguished Service Teaching Award from the Class of 2015, WUSM
2011 – Surgical Pathology Innovation Award, Department of Pathology and Laboratory Medicine, University of Pennsylvania
2011 – Leonard Berwick Residency Teaching Award, Department of Pathology and Laboratory Medicine, University of Pennsylvania
Service to the Department
2021 – 2024: Mid-Career Faculty Representative, Office of Faculty Development
2020 – Present: Education Leadership Steering Committee
2018 – 2024: Anatomic Pathology didactics organizer
2017 – 2024: Chair of the AP/CP Residency Clinical Competency Committee
2014 – 2020: Anatomic and Molecular Pathology Conference Award Committee
2014 – 2017: Clinical liaison for soft tissue and bone pathology
2014 – 2019: Supervisor of pathologists’ assistants
2013 – 2020: Associate Director of Selective (Surgical) Pathology Fellowship program (5 trainees/year)
2013 – Present: Reference pathologist for gynecologic oncology trial eligibility
2012 – 2020: Section head for gynecologic pathology in WUMS 2 pathology course (teach 8.5 lecture hours, 3 lab hours/year)
Service to the University
2021-2023: Co-Chair, Subcommittee on Medical Students, Member, Executive Committee, LCME Self-Study Task Force
2013 – Present: Member, Committee on Admissions; 2016 – Present, Chair of the South Subcommittee; 2020 – Present, Assistant Dean for Admissions
2021: Chair, Technical Standards Task Force
2020-2021: Phase 2 Design/Build Team, Obstetrics and Gynecology Clerkship, Gateway Curriculum
2020-2021: Content Expert for Basic-Clinical Science Integration (Pathology), Gateway Curriculum
2020-present: Thread leader, Genetics and Genomics, Gateway Curriculum
2014 – 2015: Member, Research and Graduate Education Committee, LCME Self-Study
2014 – 2017: Member, Executive Council of the Washington University Medical Center Alumni Association
Research Interests
My research relates to clinicopathologic correlations, prognostic factors and biomarkers in gynecologic pathology. I am interested in using molecular and clinical data to better understand tumors that are histologically mixed, such as uterine carcinosarcomas (which contain both carcinomatous and sarcomatous elements) and endometrial carcinomas with mixed endometrioid and serous components. In another set of projects, I am applying image analysis to diagnostic and predictive questions in gynecologic cancer. In my team science role, I serve as co-director of the Biospecimen, Metabolomics and Pathology (BMP) Core for the Route 66 Specialized Program of Research Excellence in Endometrial Cancer, managing tissue-related translational research needs for components of this NCI-funded SPORE.
Selected Publications
Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, Association of Cancer Care Centers, and College of American Pathologists
Publication
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer
Publication
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer
Publication
Challenges in implementation of molecular classification in early stage endometrial cancer—An NRG Oncology cooperative group mixed-methods study
Publication
Assistant

Charlsey Robinson
Administrative Assistant II
Contact
- Email: charlsey.robinson@wustl.edu
- Phone: 314-454-8462